Global Biosimilar Drug Market Growth 2022-2028

Global Biosimilar Drug Market Growth 2022-2028

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Biosimilar Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Biosimilar Drug by Country/Region, 2017, 2022 & 2028
2.2 Biosimilar Drug Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Other Types
2.3 Biosimilar Drug Sales by Type
2.3.1 Global Biosimilar Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Biosimilar Drug Sale Price by Type (2017-2022)
2.4 Biosimilar Drug Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Tumor
2.4.3 Rheumatoid Arthrtis
2.4.4 Cardiovascular
2.4.5 Other Application
2.5 Biosimilar Drug Sales by Application
2.5.1 Global Biosimilar Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Biosimilar Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Biosimilar Drug Sale Price by Application (2017-2022)
3 Global Biosimilar Drug by Company
3.1 Global Biosimilar Drug Breakdown Data by Company
3.1.1 Global Biosimilar Drug Annual Sales by Company (2020-2022)
3.1.2 Global Biosimilar Drug Sales Market Share by Company (2020-2022)
3.2 Global Biosimilar Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Biosimilar Drug Revenue by Company (2020-2022)
3.2.2 Global Biosimilar Drug Revenue Market Share by Company (2020-2022)
3.3 Global Biosimilar Drug Sale Price by Company
3.4 Key Manufacturers Biosimilar Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilar Drug Product Location Distribution
3.4.2 Players Biosimilar Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biosimilar Drug by Geographic Region
4.1 World Historic Biosimilar Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Biosimilar Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Biosimilar Drug Annual Revenue by Geographic Region
4.2 World Historic Biosimilar Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Biosimilar Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Biosimilar Drug Annual Revenue by Country/Region
4.3 Americas Biosimilar Drug Sales Growth
4.4 APAC Biosimilar Drug Sales Growth
4.5 Europe Biosimilar Drug Sales Growth
4.6 Middle East & Africa Biosimilar Drug Sales Growth
5 Americas
5.1 Americas Biosimilar Drug Sales by Country
5.1.1 Americas Biosimilar Drug Sales by Country (2017-2022)
5.1.2 Americas Biosimilar Drug Revenue by Country (2017-2022)
5.2 Americas Biosimilar Drug Sales by Type
5.3 Americas Biosimilar Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Drug Sales by Region
6.1.1 APAC Biosimilar Drug Sales by Region (2017-2022)
6.1.2 APAC Biosimilar Drug Revenue by Region (2017-2022)
6.2 APAC Biosimilar Drug Sales by Type
6.3 APAC Biosimilar Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biosimilar Drug by Country
7.1.1 Europe Biosimilar Drug Sales by Country (2017-2022)
7.1.2 Europe Biosimilar Drug Revenue by Country (2017-2022)
7.2 Europe Biosimilar Drug Sales by Type
7.3 Europe Biosimilar Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar Drug by Country
8.1.1 Middle East & Africa Biosimilar Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Biosimilar Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Biosimilar Drug Sales by Type
8.3 Middle East & Africa Biosimilar Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug
10.4 Industry Chain Structure of Biosimilar Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biosimilar Drug Distributors
11.3 Biosimilar Drug Customer
12 World Forecast Review for Biosimilar Drug by Geographic Region
12.1 Global Biosimilar Drug Market Size Forecast by Region
12.1.1 Global Biosimilar Drug Forecast by Region (2023-2028)
12.1.2 Global Biosimilar Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biosimilar Drug Forecast by Type
12.7 Global Biosimilar Drug Forecast by Application
13 Key Players Analysis
13.1 CP Guojian Pharma
13.1.1 CP Guojian Pharma Company Information
13.1.2 CP Guojian Pharma Biosimilar Drug Product Offered
13.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CP Guojian Pharma Main Business Overview
13.1.5 CP Guojian Pharma Latest Developments
13.2 Biotech Pharma
13.2.1 Biotech Pharma Company Information
13.2.2 Biotech Pharma Biosimilar Drug Product Offered
13.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Biotech Pharma Main Business Overview
13.2.5 Biotech Pharma Latest Developments
13.3 Celgen Pharma
13.3.1 Celgen Pharma Company Information
13.3.2 Celgen Pharma Biosimilar Drug Product Offered
13.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Celgen Pharma Main Business Overview
13.3.5 Celgen Pharma Latest Developments
13.4 Henlius
13.4.1 Henlius Company Information
13.4.2 Henlius Biosimilar Drug Product Offered
13.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Henlius Main Business Overview
13.4.5 Henlius Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Biosimilar Drug Product Offered
13.5.3 Amgen Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Biosimilar Drug Product Offered
13.6.3 Eli Lilly Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 Sandoz
13.7.1 Sandoz Company Information
13.7.2 Sandoz Biosimilar Drug Product Offered
13.7.3 Sandoz Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sandoz Main Business Overview
13.7.5 Sandoz Latest Developments
13.8 Changchun High Tech
13.8.1 Changchun High Tech Company Information
13.8.2 Changchun High Tech Biosimilar Drug Product Offered
13.8.3 Changchun High Tech Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Changchun High Tech Main Business Overview
13.8.5 Changchun High Tech Latest Developments
13.9 Innovent
13.9.1 Innovent Company Information
13.9.2 Innovent Biosimilar Drug Product Offered
13.9.3 Innovent Biosimilar Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Innovent Main Business Overview
13.9.5 Innovent Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Biosimilar Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Biosimilar Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Tablets
Table 5. Major Players of Other Types
Table 6. Global Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 7. Global Biosimilar Drug Sales Market Share by Type (2017-2022)
Table 8. Global Biosimilar Drug Revenue by Type (2017-2022) & ($ million)
Table 9. Global Biosimilar Drug Revenue Market Share by Type (2017-2022)
Table 10. Global Biosimilar Drug Sale Price by Type (2017-2022) & (USD/Dose)
Table 11. Global Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 12. Global Biosimilar Drug Sales Market Share by Application (2017-2022)
Table 13. Global Biosimilar Drug Revenue by Application (2017-2022)
Table 14. Global Biosimilar Drug Revenue Market Share by Application (2017-2022)
Table 15. Global Biosimilar Drug Sale Price by Application (2017-2022) & (USD/Dose)
Table 16. Global Biosimilar Drug Sales by Company (2020-2022) & (K Dose)
Table 17. Global Biosimilar Drug Sales Market Share by Company (2020-2022)
Table 18. Global Biosimilar Drug Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Biosimilar Drug Revenue Market Share by Company (2020-2022)
Table 20. Global Biosimilar Drug Sale Price by Company (2020-2022) & (USD/Dose)
Table 21. Key Manufacturers Biosimilar Drug Producing Area Distribution and Sales Area
Table 22. Players Biosimilar Drug Products Offered
Table 23. Biosimilar Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Biosimilar Drug Sales by Geographic Region (2017-2022) & (K Dose)
Table 27. Global Biosimilar Drug Sales Market Share Geographic Region (2017-2022)
Table 28. Global Biosimilar Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Biosimilar Drug Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Biosimilar Drug Sales by Country/Region (2017-2022) & (K Dose)
Table 31. Global Biosimilar Drug Sales Market Share by Country/Region (2017-2022)
Table 32. Global Biosimilar Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Biosimilar Drug Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 35. Americas Biosimilar Drug Sales Market Share by Country (2017-2022)
Table 36. Americas Biosimilar Drug Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Biosimilar Drug Revenue Market Share by Country (2017-2022)
Table 38. Americas Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 39. Americas Biosimilar Drug Sales Market Share by Type (2017-2022)
Table 40. Americas Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 41. Americas Biosimilar Drug Sales Market Share by Application (2017-2022)
Table 42. APAC Biosimilar Drug Sales by Region (2017-2022) & (K Dose)
Table 43. APAC Biosimilar Drug Sales Market Share by Region (2017-2022)
Table 44. APAC Biosimilar Drug Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Biosimilar Drug Revenue Market Share by Region (2017-2022)
Table 46. APAC Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 47. APAC Biosimilar Drug Sales Market Share by Type (2017-2022)
Table 48. APAC Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 49. APAC Biosimilar Drug Sales Market Share by Application (2017-2022)
Table 50. Europe Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 51. Europe Biosimilar Drug Sales Market Share by Country (2017-2022)
Table 52. Europe Biosimilar Drug Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Biosimilar Drug Revenue Market Share by Country (2017-2022)
Table 54. Europe Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 55. Europe Biosimilar Drug Sales Market Share by Type (2017-2022)
Table 56. Europe Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 57. Europe Biosimilar Drug Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 59. Middle East & Africa Biosimilar Drug Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Biosimilar Drug Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Biosimilar Drug Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 63. Middle East & Africa Biosimilar Drug Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 65. Middle East & Africa Biosimilar Drug Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Biosimilar Drug
Table 67. Key Market Challenges & Risks of Biosimilar Drug
Table 68. Key Industry Trends of Biosimilar Drug
Table 69. Biosimilar Drug Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Biosimilar Drug Distributors List
Table 72. Biosimilar Drug Customer List
Table 73. Global Biosimilar Drug Sales Forecast by Region (2023-2028) & (K Dose)
Table 74. Global Biosimilar Drug Sales Market Forecast by Region
Table 75. Global Biosimilar Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Biosimilar Drug Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Biosimilar Drug Sales Forecast by Country (2023-2028) & (K Dose)
Table 78. Americas Biosimilar Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Biosimilar Drug Sales Forecast by Region (2023-2028) & (K Dose)
Table 80. APAC Biosimilar Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Biosimilar Drug Sales Forecast by Country (2023-2028) & (K Dose)
Table 82. Europe Biosimilar Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Biosimilar Drug Sales Forecast by Country (2023-2028) & (K Dose)
Table 84. Middle East & Africa Biosimilar Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Biosimilar Drug Sales Forecast by Type (2023-2028) & (K Dose)
Table 86. Global Biosimilar Drug Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Biosimilar Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Biosimilar Drug Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Biosimilar Drug Sales Forecast by Application (2023-2028) & (K Dose)
Table 90. Global Biosimilar Drug Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Biosimilar Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Biosimilar Drug Revenue Market Share Forecast by Application (2023-2028)
Table 93. CP Guojian Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. CP Guojian Pharma Biosimilar Drug Product Offered
Table 95. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 96. CP Guojian Pharma Main Business
Table 97. CP Guojian Pharma Latest Developments
Table 98. Biotech Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Biotech Pharma Biosimilar Drug Product Offered
Table 100. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 101. Biotech Pharma Main Business
Table 102. Biotech Pharma Latest Developments
Table 103. Celgen Pharma Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Celgen Pharma Biosimilar Drug Product Offered
Table 105. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 106. Celgen Pharma Main Business
Table 107. Celgen Pharma Latest Developments
Table 108. Henlius Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Henlius Biosimilar Drug Product Offered
Table 110. Henlius Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 111. Henlius Main Business
Table 112. Henlius Latest Developments
Table 113. Amgen Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Amgen Biosimilar Drug Product Offered
Table 115. Amgen Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 116. Amgen Main Business
Table 117. Amgen Latest Developments
Table 118. Eli Lilly Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Eli Lilly Biosimilar Drug Product Offered
Table 120. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 121. Eli Lilly Main Business
Table 122. Eli Lilly Latest Developments
Table 123. Sandoz Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Sandoz Biosimilar Drug Product Offered
Table 125. Sandoz Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 126. Sandoz Main Business
Table 127. Sandoz Latest Developments
Table 128. Changchun High Tech Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Changchun High Tech Biosimilar Drug Product Offered
Table 130. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 131. Changchun High Tech Main Business
Table 132. Changchun High Tech Latest Developments
Table 133. Innovent Basic Information, Biosimilar Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Innovent Biosimilar Drug Product Offered
Table 135. Innovent Biosimilar Drug Sales (K Dose), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
Table 136. Innovent Main Business
Table 137. Innovent Latest Developments
List of Figures
Figure 1. Picture of Biosimilar Drug
Figure 2. Biosimilar Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilar Drug Sales Growth Rate 2017-2028 (K Dose)
Figure 7. Global Biosimilar Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Biosimilar Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Tablets
Figure 11. Product Picture of Other Types
Figure 12. Global Biosimilar Drug Sales Market Share by Type in 2021
Figure 13. Global Biosimilar Drug Revenue Market Share by Type (2017-2022)
Figure 14. Biosimilar Drug Consumed in Ankylosing Spondylitis
Figure 15. Global Biosimilar Drug Market: Ankylosing Spondylitis (2017-2022) & (K Dose)
Figure 16. Biosimilar Drug Consumed in Tumor
Figure 17. Global Biosimilar Drug Market: Tumor (2017-2022) & (K Dose)
Figure 18. Biosimilar Drug Consumed in Rheumatoid Arthrtis
Figure 19. Global Biosimilar Drug Market: Rheumatoid Arthrtis (2017-2022) & (K Dose)
Figure 20. Biosimilar Drug Consumed in Cardiovascular
Figure 21. Global Biosimilar Drug Market: Cardiovascular (2017-2022) & (K Dose)
Figure 22. Biosimilar Drug Consumed in Other Application
Figure 23. Global Biosimilar Drug Market: Other Application (2017-2022) & (K Dose)
Figure 24. Global Biosimilar Drug Sales Market Share by Application (2017-2022)
Figure 25. Global Biosimilar Drug Revenue Market Share by Application in 2021
Figure 26. Biosimilar Drug Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Biosimilar Drug Revenue Market Share by Company in 2021
Figure 28. Global Biosimilar Drug Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Biosimilar Drug Revenue Market Share by Geographic Region in 2021
Figure 30. Global Biosimilar Drug Sales Market Share by Region (2017-2022)
Figure 31. Global Biosimilar Drug Revenue Market Share by Country/Region in 2021
Figure 32. Americas Biosimilar Drug Sales 2017-2022 (K Dose)
Figure 33. Americas Biosimilar Drug Revenue 2017-2022 ($ Millions)
Figure 34. APAC Biosimilar Drug Sales 2017-2022 (K Dose)
Figure 35. APAC Biosimilar Drug Revenue 2017-2022 ($ Millions)
Figure 36. Europe Biosimilar Drug Sales 2017-2022 (K Dose)
Figure 37. Europe Biosimilar Drug Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Biosimilar Drug Sales 2017-2022 (K Dose)
Figure 39. Middle East & Africa Biosimilar Drug Revenue 2017-2022 ($ Millions)
Figure 40. Americas Biosimilar Drug Sales Market Share by Country in 2021
Figure 41. Americas Biosimilar Drug Revenue Market Share by Country in 2021
Figure 42. United States Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Biosimilar Drug Sales Market Share by Region in 2021
Figure 47. APAC Biosimilar Drug Revenue Market Share by Regions in 2021
Figure 48. China Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Biosimilar Drug Sales Market Share by Country in 2021
Figure 55. Europe Biosimilar Drug Revenue Market Share by Country in 2021
Figure 56. Germany Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Biosimilar Drug Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Biosimilar Drug Revenue Market Share by Country in 2021
Figure 63. Egypt Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Biosimilar Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2021
Figure 69. Manufacturing Process Analysis of Biosimilar Drug
Figure 70. Industry Chain Structure of Biosimilar Drug
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs